Elevation Oncology, Inc.

Elevation Oncology, Inc.verified




Market Cap:


Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.[Read more]



IPO Date


Stock Exchange




The PE Ratio as of May 2024 (TTM) for Elevation Oncology, Inc. (ELEV) is -4.25

According to Elevation Oncology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.25. This represents a change of 114.18% compared to the average of -1.98 of the last 4 quarters.

Elevation Oncology, Inc. (ELEV) Historical PE Ratio (quarterly & annually)

How has ELEV PE Ratio performed in the past?

The mean historical PE Ratio of Elevation Oncology, Inc. over the last ten years is -13.39. The current -4.25 PE Ratio has changed 3.07% with respect to the historical average. Over the past ten years (40 quarters), ELEV's PE Ratio was at its highest in in the September 2022 quarter at -0.17. The PE Ratio was at its lowest in in the March 2020 quarter at -24.15.

Quarterly (TTM)









Elevation Oncology, Inc. (ELEV) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Elevation Oncology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 72.23%

Maximum Annual PE Ratio = -0.23

Minimum Annual Increase = -94.67%

Minimum Annual PE Ratio = -46.21

Quarterly (TTM)
YearPE RatioChange

Elevation Oncology, Inc. (ELEV) Average PE Ratio

How has ELEV PE Ratio performed in the past?

The current PE Ratio of Elevation Oncology, Inc. (ELEV) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg


5-year avg


10-year avg


Elevation Oncology, Inc. (ELEV) PE Ratio vs. Peers

How is ELEV’s PE Ratio compared to its peers?

Elevation Oncology, Inc.’s PE Ratio is less than CohBar, Inc. (0), less than Ocean Biomedical, Inc. (-0.25), less than AVROBIO, Inc. (-0.30), less than Zura Bio Limited (2.05), greater than Enveric Biosciences, Inc. (-5.51), less than Hepion Pharmaceuticals, Inc. (-0.22), less than null (-0.12),

Build a custom stock screener for Elevation Oncology, Inc. (ELEV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elevation Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Elevation Oncology, Inc. (ELEV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Elevation Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Elevation Oncology, Inc.'s PE Ratio?

How is the PE Ratio calculated for Elevation Oncology, Inc. (ELEV)?

What is the highest PE Ratio for Elevation Oncology, Inc. (ELEV)?

What is the 3-year average PE Ratio for Elevation Oncology, Inc. (ELEV)?

What is the 5-year average PE Ratio for Elevation Oncology, Inc. (ELEV)?

How does the current PE Ratio for Elevation Oncology, Inc. (ELEV) compare to its historical average?